Related Links:
For additional information regarding the ROX Solution, please refer to the following links.
ROX Anastomotic Coupler System (ACS) is not yet commercially available in the United States. The ROX® Medical Anastomotic Coupler System (ACS) is intended for use in patients with stage III and IV, severe Chronic Obstructive Pulmonary Disease (COPD), and is under clincal study for a reduction in blood pressure in patients with Stage 2, drug-resistant, Hypertension. The goal of the fistula is to increase cardiac output and improve oxygen saturation (including oxygen delivery to tissue and muscles) in patients suffering from hypoxia and hypoxemia.
Potential benefits may include improved breathing, reduced symptoms of chronic bronchitis, increased exercise tolerance, and may include a reduction in high blood pressure. It is possible that the procedure may increase the oxygen content (CaO2) in patients with hypoxemia, and the cardiac output (CO), thereby increasing oxygen delivery to tissues (DO2). COPD patients may be able to walk farther, experience reduction in their severe COPD symptoms, and their quality of life may improve.
Caution: Investigational device. Limited by United States law to investigational use.
Potential benefits may include improved breathing, reduced symptoms of chronic bronchitis, increased exercise tolerance, and may include a reduction in high blood pressure. It is possible that the procedure may increase the oxygen content (CaO2) in patients with hypoxemia, and the cardiac output (CO), thereby increasing oxygen delivery to tissues (DO2). COPD patients may be able to walk farther, experience reduction in their severe COPD symptoms, and their quality of life may improve.
Caution: Investigational device. Limited by United States law to investigational use.
To learn more about acute COPD, please click here.